0001214659-21-000146.txt : 20210105
0001214659-21-000146.hdr.sgml : 20210105
20210105175257
ACCESSION NUMBER: 0001214659-21-000146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210105
DATE AS OF CHANGE: 20210105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniels Mark
CENTRAL INDEX KEY: 0001753840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 21507534
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-50803.xml
PRIMARY DOCUMENT
X0306
4
2020-12-31
0001581280
Twist Bioscience Corp
TWST
0001753840
Daniels Mark
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
See Remarks
Common Stock
2020-12-31
4
M
false
1166
26.66
A
69953
D
Common Stock
2020-12-31
4
S
false
1166
152.13
D
68787
D
Common Stock
2021-01-04
4
F
false
153
141.29
D
68634
D
Common Stock
2021-01-04
4
M
false
669
10.70
A
69303
D
Common Stock
2021-01-04
4
S
false
669
138.61
D
68634
D
Employee Stock Option (right to buy)
26.66
2020-12-31
4
M
false
1166
0
D
2028-11-18
Common Stock
1166
39676
D
Employee Stock Option (right to buy)
10.70
2021-01-04
4
M
false
669
0
D
2028-02-01
Common Stock
669
8022
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary
/s/ William Solis, as Attorney-in-Fact for Mark Daniels
2021-01-05